STRIZZI, SERGIO
STRIZZI, SERGIO
Dipartimento di Scienze Biomediche e Cliniche
Alpha-synuclein shapes monocyte and macrophage cell biology and functions by bridging alterations of autophagy and inflammatory pathways
2024 F. Limanaqi, S. Zecchini, P. Ogno, V. Artusa, C. Fenizia, I. Saulle, C. Vanetti, M. Garziano, S. Strizzi, D. Trabattoni, M. Clerici, M. Biasin
A complex remodeling of cellular homeostasis distinguishes RSV/SARS-CoV-2 co-infected A549-hACE2 expressing cell lines
2024 C. Vanetti, I. Saulle, V. Artusa, C. Moscheni, G. Cappelletti, S. Zecchini, S. Strizzi, M. Garziano, C. Fenizia, A. Tosoni, M. Broggiato, P. Ogno, M. Nebuloni, M. Clerici, D. Trabattoni, F. Limanaqi, M. Biasin
Evaluation of in vitro SARS-CoV-2 inactivation by a new quaternary ammonium compound: Bromiphen bromide
2024 S. Strizzi, G. Cappelletti, M. Biasin, A. Artasensi, L. Fumagalli, A. Casiraghi
SARS-CoV-2 natural infection, but not vaccine-induced immunity, elicits cross-reactive immunity to OC43
2024 M. Garziano, M. Cano Fiestas, C. Vanetti, S. Strizzi, M.L. Murno, M. Clerici, M. Biasin
Alpha-synuclein dynamics bridge Type-I Interferon response and SARS-CoV-2 replication in peripheral cells
2024 F. Limanaqi, S. Zecchini, I. Saulle, S. Strizzi, C. Vanetti, M. Garziano, G. Cappelletti, D. Parolin, S. Caccia, D. Trabattoni, C. Fenizia, M. Clerici, M. Biasin
An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein
2023 S. Strizzi, L. Bernardo, P. D'Ursi, C. Urbinati, A. Bianco, F. Limanaqi, A. Manconi, M. Milanesi, A. Macchi, D. Di Silvestre, A. Cavalleri, G. Pareschi, M. Rusnati, M. Clerici, P. Mauri, M. Biasin
Salivary miRNA Profiles in COVID-19 Patients with Different Disease Severities
2023 I. Saulle, M. Garziano, G. Cappelletti, F. Limanaqi, S. Strizzi, C. Vanetti, S. Lo Caputo, M. Poliseno, T. Santantonio, M. Clerici, M. Biasin
Dopamine Reduces SARS-CoV-2 Replication In Vitro through Downregulation of D2 Receptors and Upregulation of Type-I Interferons
2022 F. Limanaqi, S. Zecchini, B. Dino, S. Strizzi, G. Cappelletti, O. Utyro, C. Vanetti, M. Garziano, I. Saulle, M. Clerici, M. Biasin
UV and violet light can Neutralize SARS-CoV-2 Infectivity
2022 M. Biasin, S. Strizzi, A. Bianco, A. Macchi, O. Utyro, G. Pareschi, A. Loffreda, A. Cavalleri, M. Lualdi, D. Trabattoni, C. Tacchetti, D. Mazza, M. Clerici
Saliva and Plasma Neutralizing Activity Induced by the Administration of a Third bnt162b2 Vaccine Dose
2022 M. Garziano, O. Utyro, S. Strizzi, C. Vanetti, I. Saulle, C. Conforti, F. Cicilano, F. Ardizzone, G. Cappelletti, M. Clerici, F. Limanaqi, M. Biasin
Natural SARS-CoV-2 Infection Affects Neutralizing Activity in Saliva of Vaccinees
2022 M. Garziano, O. Utyro, M. Poliseno, T.A. Santantonio, I. Saulle, S. Strizzi, S. Lo Caputo, M. Clerici, A. Introini, M. Biasin
{UV}-A and {UV}-B Can Neutralize {SARS}-{CoV}-2 Infectivity
2021 M. Biasin, S. Strizzi, A. Bianco, A. Macchi, O.M. Utyro, G. Pareschi, A. Loffreda, A. Cavalleri, M. Lualdi, D.L. Trabattoni, C. Tacchetti, D. Mazza, M.S. Clerici